We are live on ! Find out more
IBIO icon

iBio
IBIO

53 hedge funds and large institutions have $7.63M invested in iBio in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more call options, than puts

Call options by funds: $154K | Put options by funds: $121K

0.01% less ownership

Funds ownership: 0.04% → 0.03% (-0.01%)

24% less funds holding

Funds holding: 70 → 53 (-17)

50% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 18

56% less capital invested

Capital invested by funds: $17.5M → $7.63M (-$9.87M)

59% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 27

Holders
53
Holders Change
-17
Holders Change %
-24.29%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
18
Closed
27
Calls
$154K
Puts
$121K
Net Calls
+$33K
Net Calls Change
-$1K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$1.39M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$547K
3
E
Ergoteles
New York
+$309K
4
Renaissance Technologies
Renaissance Technologies
New York
+$215K
5
Citadel Advisors
Citadel Advisors
Florida
+$150K

Top Sellers

1
BlackRock
BlackRock
New York
-$3.39M
2
State Street
State Street
Massachusetts
-$1.12M
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$475K
4
Northern Trust
Northern Trust
Illinois
-$425K
5
N
Nuveen
North Carolina
-$360K
Name Holding Trade Value Shares
Change 		Change in
Stake
YIH
26
Y-Intercept (HK)
Hong Kong
$10K +$10.8K +72 New
TSS
27
Two Sigma Securities
New York
$10K +$11.9K +79 New
PAG
28
Private Advisor Group
New Jersey
$8K -$3.46K -23 -27%
HAG
29
HighPoint Advisor Group
Illinois
$7K +$7.82K +52 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$6.79K -$902 -6 -11%
Jane Street
31
Jane Street
New York
$6K -$15.3K -102 -70%
Verition Fund Management
32
Verition Fund Management
Connecticut
$6K +$6.31K +42 New
SEEDPG
33
S.E.E.D. Planning Group
New York
$5K – – –
CSS
34
Cubist Systematic Strategies
Connecticut
$5K +$6.01K +40 New
TRCT
35
Tower Research Capital (TRC)
New York
$3K -$3.76K -25 -49%
CAGAS
36
Capital Advisory Group Advisory Services
Minnesota
$3K – – –
UCFA
37
United Capital Financial Advisors
Texas
$3K – – –
Simplex Trading
38
Simplex Trading
Illinois
$3K +$4.06K +27 New
Osaic Holdings
39
Osaic Holdings
Arizona
$2K – – –
FDCDDQ
40
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.72K – – –
UBS Group
41
UBS Group
Switzerland
$1K -$11K -73 -94%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1K -$4.06K -27 -77%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$1K -$301 -2 -29%
CHC
44
City Holding Co
West Virginia
$1K – – –
CG
45
Cutler Group
California
$1K – – –
SWA
46
SOA Wealth Advisors
New York
$1K – – –
HF
47
Halpern Financial
Virginia
$74 – – –
N
48
Nuveen
North Carolina
– -$360K -1,796 Closed
Charles Schwab
49
Charles Schwab
California
– -$252K -1,172 Closed
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
– -$97K -455 Closed
1
2
3 4

IBIO Hedge Fund Activity: Q2 2022 in Review

53 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2022, worth a combined $7.63M — down 56% from $17.5M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of IBIO and 11 opened new positions — a net loss of 16 holders — while 18 trimmed existing stakes and 9 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.39M. The largest seller was BlackRock, cutting an estimated $3.39M.

  • 53 institutional investors held iBio (IBIO) as of Q2 2022, down from 70 in Q1 2022.
  • Funds reported $7.63M of iBio stock for Q2 2022, down 56% quarter-over-quarter.
  • 11 funds opened new iBio positions in Q2 2022 and 27 closed out, a net change of -16 holders.
  • The largest iBio buyer in Q2 2022 was Millennium Management, an estimated $1.39M added.
  • The largest iBio seller in Q2 2022 was BlackRock, an estimated $3.39M sold.

Based on aggregated 13F filings for Q2 2022.